Browsing Cancer Therapeutics by author "Garrett, Michelle Dawn"
Now showing items 1-1 of 1
-
Molecular profiling and combinatorial activity of CCT068127: a potent CDK2 and CDK9 inhibitor.
Whittaker, SR; Barlow, C; Martin, MP; Mancusi, C; Wagner, S; et al. (WILEY, 2018-03-01)Deregulation of the cyclin-dependent kinases (CDKs) has been implicated in the pathogenesis of multiple cancer types. Consequently, CDKs have garnered intense interest as therapeutic targets for the treatment of cancer. ...